Health economic evaluation of treatments for Alzheimer's disease: impact of new diagnostic criteria.
about
Dementia Still Diagnosed Too Late - Data from the Czech Republic.Acupuncture for patients with Alzheimer's disease: a systematic review protocol.Resource utilisation, costs and clinical outcomes in non-institutionalised patients with Alzheimer's disease: 18-month UK results from the GERAS observational study.Gender's Effects to the Early Symptoms of Alzheimer's Disease in 5 Asian Countries.Roles of O-GlcNAcylation on amyloid-β precursor protein processing, tau phosphorylation, and hippocampal synapses dysfunction in Alzheimer's disease.B-vitamins are potentially a cost-effective population health strategy to tackle dementia: Too good to be true?An economic model of advance care planning in Australia: a cost-effective way to respect patient choice.Potential for intermittent stimulation of nucleus basalis of Meynert to impact treatment of alzheimer's disease.Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry.Challenges and recommendations for the health-economic evaluation of primary prevention programmes for dementia.A tale of two reports: what recent publications from the Alzheimer's Association and Institute of Medicine say about the state of the field.Perspectives on Communicating Biomarker-Based Assessments of Alzheimer's Disease to Cognitively Healthy Individuals.An assessment of direct and indirect costs of dementia in Brazil.Early symptoms of Alzheimer's disease in Japan and Taiwan.Targeting Alzheimer's Disease at the Right Time and the Right Place: Validation of a Personalized Approach to Diagnosis and Treatment.Dual-phase amyloid PET: hitting two birds with one stone.9th Key symposium introduction: updating Alzheimer's disease diagnosis implications for prevention and treatment.The Face-Name Associative Memory Test as a Tool for Early Diagnosis of Alzheimer's Disease
P2860
Q30968951-8FDF6A15-9555-4595-8344-1D7E2CA94F67Q34071799-592471DE-0DFD-40B9-B919-C8C07E3F753EQ36204262-DA13C82D-2902-4D59-9397-733EDAC00E98Q36327784-A82B8E96-8865-4E2B-9B9B-025122F2CA26Q38808280-B49628BC-284B-451D-A72D-8C0CBC48FBC1Q42656200-751E32AF-47BD-4090-AB98-E5C11E5EF3AEQ47124793-5671AE96-F603-4AB4-860B-1392459B507CQ47131101-F5FF77D6-5E8E-4EC1-A40B-27B4F5967089Q47587631-CDE05345-AC87-4FE1-A480-0C1E1E96D0B5Q47595477-81DE21DB-D083-42CD-8922-79761B197481Q47946369-93F7477C-F4BE-476B-B326-F6F496514164Q50421914-20F92EC9-9417-4ED3-AF68-C36DC044994DQ50533393-133A52E4-E7F6-4A75-AB9F-6FA3FDCC2168Q50573756-64176E07-5201-41B8-8677-1F9F4E1D6DE0Q51765788-B486DDAE-4D8E-4DFC-9B86-945CD312E1E6Q52983463-7B72A498-BB15-4F9C-AE8E-333B623D0A1CQ53462143-66F0D19C-2F63-4BA9-ACFA-51ABF7DEF284Q57169446-2A40F546-32EE-40DC-A134-EAF680311AB8
P2860
Health economic evaluation of treatments for Alzheimer's disease: impact of new diagnostic criteria.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Health economic evaluation of ...... ct of new diagnostic criteria.
@en
Health economic evaluation of ...... ct of new diagnostic criteria.
@nl
type
label
Health economic evaluation of ...... ct of new diagnostic criteria.
@en
Health economic evaluation of ...... ct of new diagnostic criteria.
@nl
prefLabel
Health economic evaluation of ...... ct of new diagnostic criteria.
@en
Health economic evaluation of ...... ct of new diagnostic criteria.
@nl
P2093
P2860
P50
P356
P1476
Health economic evaluation of ...... act of new diagnostic criteria
@en
P2093
A S Khachaturian
M Kramberger
S Gauthier
P2860
P304
P356
10.1111/JOIM.12167
P407
P577
2014-03-01T00:00:00Z